Norepinephrine-mediated Regulation of 5HT1 Receptor Functioning in Human Platelets

被引:0
|
作者
M. L. Trincavelli
S. Cuboni
M. Montali
S. Santaguida
A. Lucacchini
C. Martini
机构
[1] University of Pisa,Department of Psychiatry, Neurobiology, Pharmacology and Biotechnology
来源
Neurochemical Research | 2008年 / 33卷
关键词
5HT1 receptors; Human platelets; Receptor desensitisation; Norepinephrine; Adrenergic receptors;
D O I
暂无
中图分类号
学科分类号
摘要
Adaptive changes in serotonergic 5HT1 receptor signalling are believed to underlie the therapeutic effectiveness of antidepressant drugs. Since cells are continuously exposed to neurotransmitters/neuromodulators, spatially and temporally integrated, the responsiveness of a receptor system is dependent upon the physio-pathological state of the cell and the interaction between different neurotransmitters. In the present work, we investigated heterologous regulation of 5HT1 receptors induced by norepinephrine (NE) in human platelets. NE platelet treatment induced a time and concentration dependent 5HT1 receptor desensitisation mediated by both alpha and beta receptors through activation of intracellular protein kinases. In particular NE, through PKC activation, regulated 5HT1 receptor phosphorylation on threonine residues, causing in turn serotonin receptor-G protein uncoupling and functional responsiveness drop. These results suggest that high NE levels (released i.e. during stress disorders) may play an important role in regulating the 5HT1 responsiveness and in controlling effectiveness of drugs acting on these neurotransmitter systems.
引用
收藏
页码:1292 / 1300
页数:8
相关论文
共 50 条
  • [1] Norepinephrine-mediated regulation of 5HT1 receptor functioning in human platelets
    Trincavelli, M. L.
    Cuboni, S.
    Montali, M.
    Santaguida, S.
    Lucacchini, A.
    Martini, C.
    NEUROCHEMICAL RESEARCH, 2008, 33 (07) : 1292 - 1300
  • [2] REGULATION OF NOREPINEPHRINE-MEDIATED VASCULAR CONTRACTILITY
    LEGAN, E
    ROTH, B
    NAKAKI, T
    CHUANG, D
    PARRILLO, J
    CHERNOW, B
    CRITICAL CARE MEDICINE, 1985, 13 (04) : 278 - 278
  • [3] NEUROLEPTIC DRUGS AND 5HT1 RECEPTOR - DIFFERENT POTENCIES OF VARIOUS NEUROLEPTIC DRUGS ON 5HT1 RECEPTORS IN DISCRETE REGIONS OF THE RAT-BRAIN
    HARADA, T
    SATO, M
    OTSUKI, S
    FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1985, 39 (04): : 551 - 557
  • [4] Prolonged Sumatriptan Treatment Differentially Alters 5HT1 Receptor-mediated Signalling In Rat Trigeminal Ganglion
    Debner, Emily Katherine
    Jennings, Elaine
    Chavera, Teresa
    Clarke, William
    Berg, Kelly
    FASEB JOURNAL, 2019, 33
  • [5] Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes
    Perez, M
    Jorand-Lebrun, C
    Pauwels, PJ
    Pallard, I
    Halazy, S
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (11) : 1407 - 1412
  • [6] Overdose of Selective Serotonin (5HT1) Agonists
    Prasa, D.
    Reinecke, H. J.
    Rauber-Luethy, C.
    Seidel, C.
    Hoffmann-Walbeck, P.
    Gerber-Zupan, G.
    Faerber, E.
    Stedtler, U.
    Genser, D.
    CLINICAL TOXICOLOGY, 2012, 50 (04) : 324 - 324
  • [7] POSSIBLE RELATIONSHIP BETWEEN ANTIMANIC EFFECT AND ACTIVITY OF ZOTEPINE TO 5HT1 RECEPTOR
    HARADA, T
    EBARA, T
    OTSUKI, S
    FOLIA PSYCHIATRICA ET NEUROLOGICA JAPONICA, 1984, 38 (04): : 473 - 480
  • [8] Cost analysis of migraine pharmacotherapy with selective 5HT1 receptor agonists in Ukraine
    Hrynkiv, Yaryna
    Zaliska, Olha
    Maksymovych, Nataliia
    Blavatska, Oksana
    PHARMACIA, 2021, 68 (01) : 235 - 241
  • [9] Synthesis of carbon-14 labelled indolic 5HT1 receptor agonists
    Waterhouse, Ian
    Cable, Karl M.
    Fellows, Ian
    Wipperman, Mark D.
    Sutherland, Derek R.
    Journal of Labelled Compounds and Radiopharmaceuticals, 1996, 38 (11) : 1021 - 1030
  • [10] Synthesis of Carbon-14 Labelled Indolic 5HT1 Receptor Agonists
    J Labelled Compd Radiopharm, 11 (1021):